CN Stock MarketDetailed Quotes

301333 R&G PharmaStudies

Watchlist
  • 57.41
  • -1.59-2.69%
Trading Dec 5 13:56 CST
5.54BMarket Cap45.78P/E (TTM)

R&G PharmaStudies Key Stats

EPS
According to the latest financial report of R&G PharmaStudies, the latest earnings per share (TTM) for the company is 0.88. Investing in companies with strong earnings per share can potentially provide higher returns.

Currency: CNY

Cumulative Quarterly

Loading...

BVPS
Analyzing a company's fundamentals? Check out R&G PharmaStudies's latest financial report to see how much their book value per share (BVPS) is currently at 18.60.

Currency: CNY

Cumulative Quarterly

Loading...

Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of R&G PharmaStudies shows that the company's current ratio is 4.70, indicating healthy liquidity.

Currency: CNY

Cumulative Quarterly

Loading...

Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of R&G PharmaStudies, the quick ratio is 4.55, indicating that the company can meet its short-term debt obligations.

Currency: CNY

Cumulative Quarterly

Loading...

ROE
Want to learn more about the financial health of R&G PharmaStudies? The latest ROE figure is 4.78%, indicating that the company has stable profitability.

Currency: CNY

Cumulative Quarterly

Loading...

ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of R&G PharmaStudies, the total asset return on investment (ROA) is 3.93%.

Currency: CNY

Cumulative Quarterly

Loading...

Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check R&G PharmaStudies's latest financial report to see how their gross margin is doing - currently at 39.19%.

Currency: CNY

Cumulative Quarterly

Loading...

Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of R&G PharmaStudies, the net profit margin is 15.29%, which is a good sign for its profitability.

Currency: CNY

Cumulative Quarterly

Loading...

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data